WuXi Biologics (Cayman) I...

OTC: WXXWY · Real-Time Price · USD
7.99
0.29 (3.77%)
At close: Aug 15, 2025, 3:33 PM
7.99
0.00%
After-hours: Aug 15, 2025, 02:02 PM EDT

WuXi Biologics (Cayman) Cash Flow Statement

Financials in CNY. Fiscal year is January - December.
Fiscal Year Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
Period Ending Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
Net Income
3.34B 1.5B 1.7B 1.7B 1.89B 2.54B 1.55B 1.84B
Depreciation & Amortization
653.26M 783.79M 584.69M 584.69M 299.72M 500.95M 149.65M 332.13M
Stock-Based Compensation
525.45M 690.14M 637.03M 637.03M 697.25M 599.51M 355.33M 222.62M
Other Working Capital
-1.16B n/a -150.57M -150.57M -100.14M n/a -551.77M n/a
Other Non-Cash Items
201.62M -1.67B -139.55M -139.55M 3.3B -2.18B 3.36B -1.6B
Deferred Income Tax
n/a n/a n/a n/a 1.3B n/a 1.87B n/a
Change in Working Capital
-800.5M n/a -448.17M -448.17M -2.1B n/a -2.78B n/a
Operating Cash Flow
3.92B 1.3B 2.33B 2.33B 4.08B 1.46B 2.63B 798M
Capital Expenditures
-2.06B -1.87B -2.12B -2.12B -3.18B -2.68B -2.43B -4.07B
Cash Acquisitions
n/a n/a n/a n/a -1.04M -130.44M -145.37M -2.04B
Purchase of Investments
-11.43B n/a -7.54B -7.54B n/a n/a n/a n/a
Sales Maturities Of Investments
10.89B n/a 7.82B 7.82B n/a n/a n/a n/a
Other Investing Acitivies
-960.58M 1.48B 130.99M 130.99M -360.54M 452.16M 719.77M -1.63B
Investing Cash Flow
-3.56B -382.52M -1.61B -1.61B -3.55B -2.36B -1.86B -7.74B
Debt Repayment
559.61M -69.51M -409.23M -409.23M n/a -11.57M n/a 326.83M
Common Stock Repurchased
-531.56M -1.23B -458.46M -458.46M -2.11B -691.06M -2.52B n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-1.32B -171.69M 1.85B 1.85B -259.25M 483.69M -488.96M 10.89B
Financial Cash Flow
-1.27B -1.48B 980.58M 980.58M -2.37B -218.94M -3.01B 11.22B
Net Cash Flow
-874.35M 9.15B 3.27B 3.27B -1.74B -867.99M -2.28B 4.19B
Free Cash Flow
1.85B -565.26M 218.6M 218.6M 899.87M -1.23B 198.58M -3.28B